News

In a recent study, higher rates of food insecurity were found among low-income families with children in the United States.

In a recent study, the effects on bone mass did not differ between groups of infants with different levels of vitamin D supplementation.

HHS roadmap says some flexibilities won’t be affected, but AAFP wants assurances in policies to avoid disruptions for doctors, patients.

While many caregivers want to increase their child’s fruit and vegetable intake, barriers keep them from receiving fresh produce.

In doing so, the country met the new target of the World Health Organization.

A recent study examined the window of susceptibility for recurrent acute otitis media in young children, along with developing predictive models and determining the frequency of tympanostomy tubes use.

The 2023 changes include vaccines for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

In a recent study, the use of text messages alongside financial incentives increased epinephrine auto-injector carrying among adolescents.

Linaclotide (LINZESS; Ironwood Pharmaceuticals) has been granted Priority Review by the US Food and Drug Administration for treating pediatric patients with functional constipation.

In a recent statement, the US Food and Drug Administration warned pharmacies and health care providers about unsafe aluminum levels for pediatric patients in Hospira’s unapproved potassium phosphates drug product.

A supplemental New Drug Application (sNDA) for abrocitinib (CIBINQO; Pfizer) in adolescents has been approved by the US Food and Drug Administration.

In a recent study, significant racial and ethnic inequalities were found in high-risk infant follow-up programs.

New research into the use of ustekinumab compared to other treatments for psoriasis sheds light on risk for outpatient infections.

In a recent study, edible cannabis exposure and cases of significant toxicity in children aged 5 years or less had increased in the past 5 years.

In a recent study, electronic health record-based detection showed increased accuracy in early autism screening.

A recent study highlighted new information on racial disparities in health care for Black and Hispanic pediatric patients with atopic dermatitis.

In a recent study, children aged under 5 years with COVID-19 more often presented with severe illness when comorbid with another respiratory illness.

More contagious but less severe, XBB takes over as dominant Omicron strain of COVID-19

An article published in Pediatric Investigation discussed the advantages of using RNA-sequencing when diagnosing human genetic disorders.

An interview with Victoria Barrio, MD, and Fabiana Castro Porto Silva Lopes, MD, about the Society for Pediatric Dermatology and its efforts to address diversity in the dermatology field.

In a recent study, physical examinations conducted through telemedicine saw consistent results with those from in-person examinations.

While treatment discontinuation because of adverse events was more likely when taking dietary therapies for treating childhood drug-resistant epilepsy, reduction of seizures and seizure freedom were significantly more common.

After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.

Lanadelumac (TAKHZYRO; Takeda) has received an approval for a supplemental Biologics License Application to prevent hereditary angioedema attacks in pediatric patients aged 2 years and older.

A systematic review of nearly 100 published studies provides an overview of sex-based disparities in the care of pediatric patients with type 1 diabetes.

In a recent study, the safety and efficacy of ceftolozane and tazobactam was similar to meropenem for treating complicated urinary tract infection in children.

The same risk was not found for offspring of fathers with primary immunodeficiencies.

In a recent study, infants aged under 2 years had poorer performance in executive function when spending more hours per day using screens.

In a recent study, it was found that while clinical findings and outcomes of multisystem inflammatory syndrome in children (MIS-C) were consistent across the COVID-19 pandemic, incidence decreased over time.

The US Food and Drug Administration has approved the use of a pre-filled tezepelumab (TEZSPIRE; Amgen and AstraZeneca) pen in patients aged 12 years and older with severe asthma.